← FDA Drug Approvals (Drugs@FDA)

ETOMIDATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2017-02-07

Drug application

FDA Application #

ANDA201044

Application type

Abbreviated New Drug Application (Generic)

Brand name

ETOMIDATE

Generic name

ETOMIDATE

Active ingredients

ETOMIDATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

MYLAN LABS LTD

Manufacturer

Mylan Institutional LLC

First approval

2017-02-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown